"Unsere Hautarztpraxis im Zentrum von Bonn bietet Ihnen die gesamte Bandbreite an allgemeiner, operativer und ästhetischer Dermatologie sowie zeitgemäßer schonender Lasermedizin. Der leitende Facharzt unserer Praxis, Dr. Reinhold, blickt auf eine langjährige Berufserfahrung im Bereich der Dermatologie zurück. Wir unterstützen Sie, sich in Ihrer Haut Wohl zufühlen. Vereinbaren Sie jetzt einen Termin mit uns."

During the past decade, MVZ Dermatologisches Zentrum Bonn GmbH conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "MVZ Dermatologisches Zentrum Bonn GmbH" #1 sponsor was "Biofrontera Bioscience GmbH" with 1 trials, followed by "Infectopharm Arzneimittel GmbH" with 1 trials sponsored, "Janssen-Cilag G.m.b.H" with 1 trials sponsored, "Pierre Fabre Medicament" with 1 trials sponsored and "Smith & Nephew Orthopaedics AG" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "MVZ Dermatologisches Zentrum Bonn GmbH" #1 collaborator was "Clinact" with 1 trials as a collaborator and "Gesellschaft für Therapieforschung mbH" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "MVZ Dermatologisches Zentrum Bonn GmbH" are "Actinic Keratoses" (2 trials), "Actinic Keratosis" (2 trials), "Psoriasis" (1 trials) and "Wound" (1 trials). Many other conditions were trialed in "MVZ Dermatologisches Zentrum Bonn GmbH" in a lesser frequency.

Most popular intervention types in "MVZ Dermatologisches Zentrum Bonn GmbH" are "Drug" (5 trials), "Device" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "5-fluorouracil 4% (Tolak)" (1 trials), "ALLEVYN Gentle border" (1 trials), "BF-200 ALA gel" (1 trials), "Dexeryl" (1 trials) and "Guselkumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "MVZ Dermatologisches Zentrum Bonn GmbH" are 6 trials for "All" genders.

Currently, there are NaN active trials in "MVZ Dermatologisches Zentrum Bonn GmbH". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in MVZ Dermatologisches Zentrum Bonn GmbH, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in MVZ Dermatologisches Zentrum Bonn GmbH, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".